Outcomes treating stage III non-small cell lung carcinoma with curative-intent radiotherapy and concurrent carboplatin-paclitaxel chemotherapy.

about

Outcomes treating stage III non-small cell lung carcinoma with curative-intent radiotherapy and concurrent carboplatin-paclitaxel chemotherapy.

Item

http://www.wikidata.org/entity/Q51687784

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Outcomes treating stage III no ...... latin-paclitaxel chemotherapy.

@en

Outcomes treating stage III no ...... latin-paclitaxel chemotherapy.

@nl

type

Item

label

Outcomes treating stage III no ...... latin-paclitaxel chemotherapy.

@en

Outcomes treating stage III no ...... latin-paclitaxel chemotherapy.

@nl

prefLabel

Outcomes treating stage III no ...... latin-paclitaxel chemotherapy.

@en

Outcomes treating stage III no ...... latin-paclitaxel chemotherapy.

@nl

P1476

Outcomes treating stage III no ...... latin-paclitaxel chemotherapy.

@en

P2093

Dannie Zarate

http://www.w3.org/2001/XMLSchema#string

Elizabeth McCaffrey

http://www.w3.org/2001/XMLSchema#string

Gang Tao Mai

http://www.w3.org/2001/XMLSchema#string

Keith Horwood

http://www.w3.org/2001/XMLSchema#string

Margaret Dauth

http://www.w3.org/2001/XMLSchema#string

Margaret McGrath

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced inoperable non-small-cell lung cancer.

Analysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer.

Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Cigarette smoking and gemcitabine-induced neutropenia in advanced solid tumors.

Radiation dose-volume effects in the lung.

P304

428-434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CRJ.12233

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark B Pinkham

M H Lehman

Hon Trinh

P577

2014-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25353367

http://www.w3.org/2001/XMLSchema#string